Antithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
about
sameAs
A review of picotamide in the reduction of cardiovascular events in diabetic patientsCritical limb ischemia: advanced medical therapyAntithrombotic treatment for peripheral arterial diseaseMasterclass series in peripheral arterial disease. Antiplatelet therapy for peripheral arterial disease and claudicationEarly Thrombosuction and Tirofiban Use in Knee and Below-Knee Arterial Thrombosis.VA Vascular Injury Study (VAVIS): VA-DoD extremity injury outcomes collaboration.Review of pharmacology and physiology in thrombolysis interventions.Diagnosis and management of peripheral artery disease in women.Arterial embolism.Medical management and cardiovascular risk reduction in peripheral arterial diseaseInternational guidelines: Adoption or adaptation by the Saudi Heart Association?Peripheral arterial disease: Epidemiology, natural history, diagnosis and treatment.Physiology in medicine: peripheral arterial diseaseOral antiplatelet therapy in the secondary prevention of atherothrombotic events.Audit of anticoagulation after embolectomy for acute ischaemia.Evidence-based management strategies for treatment of chronic wounds.Antithrombotic therapy for the CardioWest temporary total artificial heart.Preventive aspects in peripheral artery disease.Diagnosis and treatment of peripheral arterial disease in CKD patients.Medical management of critical limb ischaemia: where do we stand today?Axillobifemoral Bypasses: Reappraisal of an Extra-Anatomic Bypass by Analysis of Results and Prognostic Factors.From the liver to the foot: a case of systemic embolism and acrometastasis in hepatocellular carcinoma.Purification and characterization of mutant miniPlasmin for thrombolytic therapy.Saddle arterial embolus in a patient with Down syndrome.Acute Limb Ischemia-Much More Than Just a Lack of Oxygen.Sarpogrelate, a 5-hT2A receptor antagonist in intermittent claudication. A phase II European study.Intra-arterial injection of sclerosants: Report of three cases treated with systemic steroids.
P2860
Q24681255-B3810C98-D56F-4606-A92D-5CA0F2D2BDD6Q26995245-18252335-DBF6-4778-AF0E-A49B16DD22B1Q28200650-D65F683A-DF12-4F54-8243-FCB5BC46ED11Q28217376-49C8F44D-D9C8-4763-9AB7-AAC628226187Q33648076-0F8BCD34-4AA7-4891-86CF-86EF9AC08131Q35083475-335C6314-FD54-4CAF-AD71-F4A22AFAEA0EQ35882918-12D751AD-277A-496D-9129-AAD625722D2CQ36493454-999E5E0C-8DE5-4B95-85B5-425D3031F9F5Q36879563-D93C3952-9380-45EF-A9E0-C95ACBCD1F1FQ36981330-62289473-1C22-4350-A843-C6C38CD810E3Q37055599-665C10E4-DE36-4B43-8B36-A2B57E75C88CQ37321632-3793659D-E2CA-42E4-A882-3BD31141C362Q37346156-E2AC2335-2269-47EB-B74F-2B425BF42EB9Q37492564-761CFC50-7ED3-4F89-A998-4AAC3487800CQ37532738-7B226F6E-CD37-4591-B433-0F484CD16E30Q37541701-CEC93E4E-FE29-4957-BEB0-E634EDE527B7Q37733290-8BCAFFF8-8421-49E4-AD0D-647E72E2A91FQ37984281-41E10DA7-AEBD-4CC3-9DCC-88864CD04093Q38052160-9081A86B-D8CA-437D-98FB-E1E02CDFC4DCQ38116561-F2AB1C9D-61DA-4EAC-9E6D-7C31060F2EFDQ40121104-389DC9ED-E75A-43DB-A84F-48A114A4A210Q41807487-F94C3DB2-621A-418C-ACD7-94DE0879F015Q43072712-3A67EFFC-C0DE-4882-9775-92EFABAF7430Q46886501-B365B4E5-CF1F-4FEB-AFB6-BEEE2BF830EDQ47646431-5AC73A0D-026C-4A85-BAF1-D863885511B3Q51792444-9BF2A9E8-14FC-4054-9F5E-D2E87148BA14Q53558990-70D60D86-644E-49EE-848A-63A89CDE63AA
P2860
Antithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Antithrombotic therapy in peri ...... botic and Thrombolytic Therapy
@ast
Antithrombotic therapy in peri ...... botic and Thrombolytic Therapy
@en
Antithrombotic therapy in peri ...... botic and Thrombolytic Therapy
@nl
type
label
Antithrombotic therapy in peri ...... botic and Thrombolytic Therapy
@ast
Antithrombotic therapy in peri ...... botic and Thrombolytic Therapy
@en
Antithrombotic therapy in peri ...... botic and Thrombolytic Therapy
@nl
prefLabel
Antithrombotic therapy in peri ...... botic and Thrombolytic Therapy
@ast
Antithrombotic therapy in peri ...... botic and Thrombolytic Therapy
@en
Antithrombotic therapy in peri ...... botic and Thrombolytic Therapy
@nl
P2093
P1433
P1476
Antithrombotic therapy in peri ...... botic and Thrombolytic Therapy
@en
P2093
G Patrick Clagett
Marco Tangelder
Mark R Jackson
Michael Sobel
Raymond Verhaeghe
P304
P356
10.1378/CHEST.126.3_SUPPL.609S
P407
P433
P577
2004-09-01T00:00:00Z